Expert Commentary

What do the genes GDF15 and IGFBP7 mean for the future of hyperemesis gravidarum treatment?

Publish date: June 4, 2018
By
John T. Repke, MD
Author and Disclosure Information

WHAT DOES THIS MEAN FOR PRACTICE?

  • Genes GDF15 and IGFBP7 have been associated with hyperemesis gravidarum

  • The association may allow for future techniques in the prediction, prevention, and treatment of hyperemesis gravidarum


 

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel .

Citation: Fejzo MS, Sazonova OV, Fah Sathirapongsasuti J, et al. Placenta and appetite genes GDF15 and IGFBP7 are associated with hyperemesis gravidarum. Nature Communications. 2018;9:1178.

Recommended Reading

Delivering bad news in obstetric practice
MDedge ObGyn
Lessons from a daunting malpractice event
MDedge ObGyn
How more midwives may mean healthier mothers
MDedge ObGyn
Incision site for cesarean delivery is important in infection prevention
MDedge ObGyn
Treatment includes surgery
MDedge ObGyn
Rash goes undetected
MDedge ObGyn
Tip for when using phenazophyridine
MDedge ObGyn
FP can perform the circumcision
MDedge ObGyn
Neonatal deaths lower in high-volume hospitals
MDedge ObGyn
Pregnancy may be ideal time to consider switching MS drugs
MDedge ObGyn